InveniAI, a wholly owned subsidiary and technology spin-out of BioXcel Corporation, has pioneered the application of artificial intelligence (AI) and machine learning (ML) to transform innovation across healthcare and other industries. InveniAI is leveraging AI and ML to harness petabytes of disparate data sets to recognize and unlock value. Our domain expertise spans AI-based innovation monitoring to AI-based drug discovery. Our numerous industry collaborations with Big Pharma, Specialty Pharma, and BioPharma, showcase the value of our platform in recognizing complex patterns and associations to complement and amplify human expertise. We continue to collaborate with our industry partners to address cutting-edge problems across the value chain from internal to external innovation and to enhance corporate decision making. We are headquartered in Branford, CT, USA.
- Our domain expertise spans AI-based innovation monitoring to AI-based drug discovery